ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
- RxCUI
- 994237
- RxNorm name
- ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
- Display name
- ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
- Full name
- ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:09
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE | Bryant Ranch Prepack | 95a33c9b-79a6-47c7-8433-fc217950b88f | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 994237 |
| Ascomp with Codeine | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE | Breckenridge Pharmaceutical, Inc. | 243a6aea-0f48-42a9-a85e-ff247ab94336 | 2026-02-09 | Boxed warning, Warnings, Adverse reactions | 994237 |
| BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE | Amneal Pharmaceuticals of New York, LLC | 828e30fa-7bb1-486b-80ee-806fce45e4e4 | 2026-01-15 | Boxed warning, Warnings, Adverse reactions | 994237 |
| Ascomp with Codeine | BUTALBITAL, ASPIRIN, CAFEINE, AND CODEINE PHOSPHATE | LGM PHARMA SOLUTIONS, LLC | 1cab3106-1064-4b42-892b-39f405d9e02f | 2025-11-01 | Boxed warning, Warnings, Adverse reactions | 994237 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 95a33c9b-79a6-47c7-8433-fc217950b88f | butalbital 50 MG / aspirin 325 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [PSN] · aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SCD] · ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SY] | 3 | 16 | These highlights do not include all the information needed to use ASCOMP with Codeine safely and effectively. See full prescribing information for ASCOMP with Codeine. ASCOMP with Codeine (butalbital, aspirin, caffeine, and codeine phosphate, USP) capsules, for oral use, CIII Initial U.S. Approval: 1990 | 20260527 |
| 1cab3106-1064-4b42-892b-39f405d9e02f | butalbital 50 MG / aspirin 325 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [PSN] · aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SCD] · ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SY] | 3 | 15 | These highlights do not include all the information needed to use Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP safely and effectively. See full prescribing information for Butalbital, Aspirin, Caffe i ne, and Codeine Phosphate Capsules, USP . B utalbital, A spirin, C affeine, and C odeine P hosphate C apsules, USP for oral use, CIII Initial U.S. Approval: 1990 | 20251101 |
| 243a6aea-0f48-42a9-a85e-ff247ab94336 | butalbital 50 MG / aspirin 325 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [PSN] · aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SCD] · ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SY] | 3 | 13 | These highlights do not include all the information needed to use ASCOMP with Codeine safely and effectively. See full prescribing information for ASCOMP with Codeine. ASCOMP with Codeine (butalbital, aspirin, caffeine, and codeine phosphate, USP) capsules, for oral use, CIII Initial U.S. Approval: 1990 | 20260209 |
| ca3fe6e9-21ad-4fba-a602-e1c364cf3981 | butalbital 50 MG / aspirin 325 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [PSN] · aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SCD] · ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SY] | 3 | 11 | These highlights do not include all the information needed to use ASCOMP with CODEINE (Butalbital, Aspirin, Caffeine, and Codeine Phosphate, USP Capsules) safely and effectively. See full prescribing information for ASCOMP with CODEINE (Butalbital, Aspirin, Caffeine, and Codeine Phosphate, USP) capsules, for oral use, CIII Initial U.S. Approval: 1990 | 20200212 |
| 828e30fa-7bb1-486b-80ee-806fce45e4e4 | butalbital 50 MG / aspirin 325 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [PSN] · aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SCD] · ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SY] | 3 | 8 | These highlights do not include all the information needed to use BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE capsules safely and effectively. See full prescribing information for BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE. BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE capsules, USP, for oral use Initial U.S. Approval: 1990 | 20260115 |
| 787cda7d-7aa4-4909-8e5c-f2fcf68828e4 | butalbital 50 MG / aspirin 325 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [PSN] · aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SCD] · ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SY] | 3 | 1 | 20100629 | |
| c8b93fc1-472c-4890-8d02-2ee4f7175c22 | butalbital 50 MG / aspirin 325 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [PSN] · aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SCD] · ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SY] | 3 | 1 | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE CAPSULES, USP | 20071025 |